Angeliq is a new drug for treatment of menopausal symptoms,it combines natural17b-estradiol (E2)1mg with the novel progestin, drospirenone (DRSP)2mg。This paper reviews recent clinical trial data and animals experiments demonstrating the efficacy and safety of Angeliq as HRT in postmenopausal women. Angeliq provides symptomatic relief of vasomotor symptoms and improvement in genitourinary atrophy. Angeliq also decreases blood pressure in women with elevated blood pressure, and has a favorable impact on cholesterol and triglyceride levels.The favorable efficacy and safety profile of Angeliq, and potential for long-term health benefits, represents a new option for the effective management of menopausal symptoms in the European and American countries... |